Sort   by:  
 Page size 
UnknownPreventing malaria in the Peruvian Amazon: a qualitative study in Iquitos, Peru.
Not available
S-EPMC5771103 | biostudies-literature
UnknownPatients' perspectives on factors facilitating adherence to tuberculosis treatment in Iquitos, Peru: a qualitative study.
Not available
S-EPMC8048224 | biostudies-literature
UnknownA Toll-receptor map underlies structural brain plasticity.
Not available
S-EPMC7077983 | biostudies-literature
UnknownA phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.
Not available
S-EPMC6461928 | biostudies-literature
UnknownIntravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.
Not available
S-EPMC9103071 | biostudies-literature
UnknownA Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Not available
S-EPMC10539020 | biostudies-literature
UnknownQuality of life, long-term survivors and long-term outcome from the ABC-02 study.
Not available
S-EPMC4984909 | biostudies-literature
UnknownTebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Not available
S-EPMC9210997 | biostudies-literature
UnknownA randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).
Not available
S-EPMC5318975 | biostudies-literature
UnknownDual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Not available
S-EPMC6947485 | biostudies-literature
Sort   by:  
 Page size